Table 3 Reasons for dose reduction
Distribution of adverse effects | N | % |
|---|---|---|
Leukopenia | 20 | 30% |
Polyneuropathy | 11 | 16% |
Diarrhea | 10 | 14% |
Worsening of general condition | 6 | 9% |
Hand-foot-syndrome | 5 | 7% |
Thrombocytopenia | 5 | 7% |
Hyperemesis | 3 | 4% |
Elevated bilirubin | 2 | 3% |
Deterioration of kidney function | 1 | 1% |
Mucositis | 1 | 1% |
Not specified | 5 | 7% |